London MedTech Vicebio to be acquired by Sanofi in £1.2bn deal
A London-based MedTech developing vaccines against life threatening respiratory viral infections has been acquired by French firm Sanofi in a … Continue reading London MedTech Vicebio to be acquired by Sanofi in £1.2bn deal
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed